Form 4: Director Krogulski Boosts CPIX Stake via 10b5-1 Plan

Cumberland Pharmaceuticals Director Kenneth Krogulski acquired additional common stock through a pre-arranged 10b5-1 trading plan in September 2025.

Summary

• Kenneth Krogulski, a Director of Cumberland Pharmaceuticals Inc. (CPIX), acquired a total of 1,250 shares of common stock between September 2, 2025, and September 30, 2025.
• The acquisitions were made at prices ranging from $3.05 to $3.60 per share.
• These transactions were executed automatically pursuant to a Rule 10b5-1 trading plan adopted by Mr. Krogulski on November 14, 2024.
• Following these transactions, Mr. Krogulski's direct beneficial ownership of common stock increased from 289,779 shares to 291,031 shares.

Sentiment

Score: 7

Explanation: The sentiment is positive due to a director increasing their stake, indicating confidence in the company. The fact that it's a 10b5-1 plan suggests a long-term, pre-planned belief in the company's value, though the declining stock price during the purchase period slightly tempers the immediate positive signal.

Positives

• A Director's acquisition of company stock signals confidence in the company's future prospects and valuation.
• The purchases were made under a Rule 10b5-1 plan, indicating a pre-planned, long-term investment strategy rather than a reactive trade.

Negatives

• The share acquisition occurred during a period where the stock price generally declined from $3.54 on September 2, 2025, to $3.12 on September 30, 2025.

Future Outlook

NA

Management Comments

• The reported purchases were executed automatically under a Rule 10b5-1 trading plan adopted by the reporting person on November 14, 2024.

Industry Context

This filing is specific to insider trading activity for Cumberland Pharmaceuticals Inc. and does not provide broader industry context or trends.

Corporate Governance

Stakeholder Impact

• Shareholders may view the director's increased stake as a positive signal of management's confidence in the company's future performance and value.
• The use of a 10b5-1 plan demonstrates adherence to good corporate governance practices regarding insider trading.

Key Dates

Recommendation

A director's consistent acquisition of shares, even through a pre-arranged 10b5-1 plan, signals long-term confidence in the company's valuation and future prospects. While the stock price declined during the purchase period, the insider's willingness to increase their stake suggests a belief that the current price represents a buying opportunity.

Keywords

CPIX, Cumberland Pharmaceuticals, Kenneth Krogulski, Insider Trading, Form 4, Stock Acquisition, Director, 10b5-1 Plan, Beneficial Ownership